Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older (see Dosage & Administration and Pharmacology: Pharmacodynamics under Actions).
The use of this vaccine should be in accordance with official recommendations.